Today reported economic results for the initial quarter ended March 31.

This development is due to a reported 14.8 percent upsurge in prescriptions for Testim during the first quarter of 2010 when compared to same period in 2009 2009. General and administrative expenses for the initial quarter of 2010 increased $769,000 when compared to first quarter of 2009. The increase was mainly related to improved advisory […]

BioSante to provide LibiGel clinical trial revise at NAMS Annual Meeting BioSante Pharmaceuticals naltrexone price.

BioSante to provide LibiGel clinical trial revise at NAMS Annual Meeting BioSante Pharmaceuticals, Inc. today announced that it’ll present a LibiGel medical trial upgrade at the 21st Annual Achieving of The UNITED STATES Menopause Culture being kept from October 6-9, 2010 at the Sheraton Chicago Resort & Towers in Chicago, Illinois. A lot more than […]

Blue Care Network gets to milestone: Enrolls 100.

Related StoriesSignostics gets FDA 510k clearance for handheld bladder scannerGreater evidence-centered help necessary for depressed employees – New report from THE TASK FoundationInnovative single-make use of torque instruments utilize hard polycarbonate from BayerEmployers play an integral function in encouraging their workers to look at healthier lives. Healthy Blue Living encourages companies to provide a smoke-free […]

S ongoing Phase 2 research of palovarotene for the treating fibrodysplasia ossificans progressiva.

Related StoriesBoston Children's and Rock Health synergy to accelerate development of pediatric wellness technologiesGlan Clwyd Medical center N Wales spend money on Esaote's G-Scan MRI unit for weight-bearing scanningHeart of the Rockies Regional INFIRMARY selects Aprima EHR The inclusion of children as young as 6 years old in the ongoing Stage 2 clinical trial can […]

Large-scale biologics manufacturing unit in Cruiserath

Bristol-Myers Squibb to create a new large-scale biologics manufacturing facility in Ireland Bristol-Myers Squibb Business today announced plans to construct a fresh state-of-the-art, large-scale biologics manufacturing unit in Cruiserath, County Dublin, Ireland, that will make multiple therapies for the company’s developing biologics portfolio. Once completed, the new facility will significantly increase Bristol-Myers Squibb’s biologics developing […]